119 related articles for article (PubMed ID: 30027778)
1. A quality-by-design study to develop Nifedipine nanosuspension: examining the relative impact of formulation variables, wet media milling process parameters and excipient variability on drug product quality attributes.
Patel PJ; Gajera BY; Dave RH
Drug Dev Ind Pharm; 2018 Dec; 44(12):1942-1952. PubMed ID: 30027778
[TBL] [Abstract][Full Text] [Related]
2. Is roller milling - the low energy wet bead media milling - a reproducible and robust milling method for formulation investigation of aqueous suspensions?
Zulbeari N; Holm R
Int J Pharm; 2024 Feb; 651():123733. PubMed ID: 38142873
[TBL] [Abstract][Full Text] [Related]
3. Formulation of Aceclofenac Tablets Using Nanosuspension as Granulating Agent: An Attempt to Enhance Dissolution Rate and Oral Bioavailability.
Rahim H; Sadiq A; Ullah R; Bari A; Amin F; Farooq U; Ullah Jan N; Mahmood HM
Int J Nanomedicine; 2020; 15():8999-9009. PubMed ID: 33235448
[TBL] [Abstract][Full Text] [Related]
4. Development of Delayed Release Oral Formulation Comprising Esomeprazole Spray Dried Dispersion Utilizing Design of Experiment As An Optimization Strategy.
Patel K; Patel J; Shah S
AAPS PharmSciTech; 2023 Sep; 24(7):186. PubMed ID: 37700215
[TBL] [Abstract][Full Text] [Related]
5. Rubusoside As a Multifunctional Stabilizer for Novel Nanocrystal-Based Solid Dispersions with a High Drug Loading: A Case Study.
Liu Y; Wu Z; Chen Y; Guan Y; Guo H; Yang M; Yue P
J Pharm Sci; 2024 Mar; 113(3):699-710. PubMed ID: 37659720
[TBL] [Abstract][Full Text] [Related]
6. 24 Factorial Design Formulation Optimization and In vitro Characterization of Desloratadine Nanosuspension Prepared Using Antisolvent Precipitation.
El-Sebaiy MT; Alyami MH; Alyami HS; Kamal MA; Eissa N; Balata G; El-Nahas H
Curr Drug Deliv; 2024 Jun; ():. PubMed ID: 38867526
[TBL] [Abstract][Full Text] [Related]
7. Impact of grinding balls on the size reduction of Aprepitant in wet ball milling procedure.
Memarvar D; Yaqoubi S; Hamishehkar H; Lam M; Nokhodchi A
Pharm Dev Technol; 2024 Apr; 29(4):353-358. PubMed ID: 38528824
[TBL] [Abstract][Full Text] [Related]
8. Wet bead milling by dual centrifugation - An approach to obtain reproducible and differentiable suspensions.
Zulbeari N; Holm R
Int J Pharm; 2023 Nov; 646():123455. PubMed ID: 37776963
[TBL] [Abstract][Full Text] [Related]
9. A novel Posaconazole oral formulation using spray dried solid dispersion technology: in-vitro and in-vivo study.
Patel K; Kevlani V; Shah S
Drug Deliv Transl Res; 2024 May; 14(5):1253-1276. PubMed ID: 37952081
[TBL] [Abstract][Full Text] [Related]
10. Cyclosporine a-nanosuspension: formulation, characterization and in vivo comparison with a marketed formulation.
Nakarani M; Patel P; Patel J; Patel P; Murthy RS; Vaghani SS
Sci Pharm; 2010; 78(2):345-61. PubMed ID: 21179351
[TBL] [Abstract][Full Text] [Related]
11. Exploring the Solvent-Anti-solvent Method of Nanosuspension for Enhanced Oral Bioavailability of Lovastatin.
Patil AS; Hegde R; Gadad AP; Dandagi PM; Masareddy R; Bolmal U
Turk J Pharm Sci; 2021 Oct; 18(5):541-549. PubMed ID: 34708645
[TBL] [Abstract][Full Text] [Related]
12.
Shariare MH; Altamimi MA; Marzan AL; Tabassum R; Jahan B; Reza HM; Rahman M; Ahsan GU; Kazi M
Saudi Pharm J; 2019 Jan; 27(1):96-105. PubMed ID: 30662312
[TBL] [Abstract][Full Text] [Related]
13. Design and Solidification of Fast-Releasing Clofazimine Nanoparticles for Treatment of Cryptosporidiosis.
Zhang Y; Feng J; McManus SA; Lu HD; Ristroph KD; Cho EJ; Dobrijevic EL; Chan HK; Prud'homme RK
Mol Pharm; 2017 Oct; 14(10):3480-3488. PubMed ID: 28929769
[TBL] [Abstract][Full Text] [Related]
14. Nanosuspension based in situ gelling nasal spray of carvedilol: development, in vitro and in vivo characterization.
Saindane NS; Pagar KP; Vavia PR
AAPS PharmSciTech; 2013 Mar; 14(1):189-99. PubMed ID: 23255198
[TBL] [Abstract][Full Text] [Related]
15. Development of a Resveratrol Nanosuspension Using the Antisolvent Precipitation Method without Solvent Removal, Based on a Quality by Design (QbD) Approach.
Kuk DH; Ha ES; Ha DH; Sim WY; Lee SK; Jeong JS; Kim JS; Baek IH; Park H; Choi DH; Yoo JW; Jeong SH; Hwang SJ; Kim MS
Pharmaceutics; 2019 Dec; 11(12):. PubMed ID: 31861173
[TBL] [Abstract][Full Text] [Related]
16. Quercetin nanocrystals for bioavailability enhancement: impact of different functional stabilizers on
Zhu Y; Hu F; Shen C; Shen B; Yuan H
Pharm Dev Technol; 2024 Jun; ():1-8. PubMed ID: 38808380
[TBL] [Abstract][Full Text] [Related]
17. Design Space and QbD Approach for Production of Drug Nanocrystals by Wet Media Milling Techniques.
Peltonen L
Pharmaceutics; 2018 Jul; 10(3):. PubMed ID: 30044395
[TBL] [Abstract][Full Text] [Related]
18. Predictive computational models for assessing the impact of co-milling on drug dissolution.
Pätzmann N; O'Dwyer PJ; Beránek J; Kuentz M; Griffin BT
Eur J Pharm Sci; 2024 Jul; 198():106780. PubMed ID: 38697312
[TBL] [Abstract][Full Text] [Related]
19. Poloxamer-407-Co-Poly (2-Acrylamido-2-Methylpropane Sulfonic Acid) Cross-linked Nanogels for Solubility Enhancement of Olanzapine: Synthesis, Characterization, and Toxicity Evaluation.
Khan KU; Akhtar N; Minhas MU
AAPS PharmSciTech; 2020 May; 21(5):141. PubMed ID: 32419084
[TBL] [Abstract][Full Text] [Related]
20. Development of piperine nanoparticles stabilized by OSA modified starch through wet-media milling technique with enhanced anti-adipogenic effect in 3T3-L1 adipocytes.
Tang B; Sun J; Xiao J; Cao Y; Huang Q; Ho CT; Kou X; Lu M
Int J Biol Macromol; 2024 Jun; 272(Pt 1):132738. PubMed ID: 38825269
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
